Arrowhead Pharmaceuticals · 16 hours ago
Senior Scientist I, Quality Control
Verona, Wisconsin, United States
Full-time
Onsite
Mid, Senior Level
$90K/yr - $108K/yr
7+ years expArrowhead Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing innovative drugs for genetic diseases. The Senior Scientist I in Quality Control will support analytical testing of various pharmaceutical samples and stability studies, while also leading and mentoring co-workers.
BiotechnologyHealth CareNanotechnologyPharmaceutical
No H1B
Responsibilities
Fully knowledgeable of cGMP requirements and ICH guidelines
Works independently to meet project timelines and deliverables with minimal supervision to no supervision
Collaborates routinely with Analytical Development on procedural method transfers and may participate in the execution of method validation protocols
Performs routine analytical testing of pharmaceutical raw materials, in-process samples, finished products and stability samples using established test methods and procedures
Proficient with various analytical instrumentation theory and practice
Executes training requirements for assigned SOPs and participates in department specific training modules
Independently completes complex instrumentation for testing according to written test methods and procedural documents to analyze samples
Demonstrates proficiency with a variety of instrumentation (e.g., HPLC, GC, LC-MS, KF, FTIR, Endotoxin plate readers, and/or Raman spectroscopy) and will assist in training on instrumentation as
Is a subject matter expert in technical aspects of both instrumentation and workflow management and prioritization
Performs analyses in a timely and efficient manner to support ongoing prioritized studies
Works closely with other department personnel for efficient project execution and timely/accurate deliverables while building a relationship with respect and communication
Trains and mentors co-workers (analysts)
Shows initiative and interest in mastering new techniques and tests
Ability to track/trend data and interpret degrative changes to the product on stability
Uses stability tracking software as a repository generated results (data entry, review and approval)
Owns and leads scientific technical discussions and brainstorming sessions
Identifies and troubleshoots analytical method issues with instrumentation, general chemistry, test methodology and sample product
Communicates laboratory testing issues or challenges to laboratory management
Maintains a clear, concise, and accurate notebook
Performs technical data review on data acquired by other QC analysts as applicable
Drafts technical documents such as COAs, investigations, deviations, and CAPAs
Possesses excellent written and verbal communication skills
Embraces cGMP and ICH requirements for all associated work
Works cooperatively in a team environment
Demonstrates a high attention to detail
Calibration, maintenance, and troubleshooting of analytical equipment with little to no guidance from management
Routinely makes sound, scientific decisions independently and serves as a back-up to Laboratory Management
Demonstrates enduring flexibility and understanding with changing
Qualification
Required
M.S. in Chemistry (or related field) with 7+ years relevant laboratory experience
B.S. in Chemistry (or related field) with 9+ years of relevant laboratory experience
Fully knowledgeable of cGMP and ICH laboratory requirements and operations
Proficient and demonstrated experience with analytical instrumentation, test methodology/validations/transfers, data acquisition systems, and typical cGMP policies/practices
Benefits
Competitive salaries
Excellent benefit package
Company
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$2.45BKey Investors
Sarepta TherapeuticsSixth StreetSilence Therapeutics
2026-01-07Post Ipo Equity· $200M
2026-01-07Post Ipo Debt· $625M
2024-11-26Post Ipo Equity· $325M
Leadership Team
Christopher Anzalone
President and Chief Executive Officer
Recent News
2026-01-14
Company data provided by crunchbase